[HTML][HTML] Efficacy of high-dose polyclonal intravenous immunoglobulin in COVID-19: A systematic review

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - mdpi.com
Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

[HTML][HTML] Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - ncbi.nlm.nih.gov
Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

[HTML][HTML] Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - journalwise.acponline.org
Background: Open Access Systematic Review Efficacy of High-Dose Polyclonal Intravenous
Immunoglobulin in COVID-19: A Systematic Review by Daniele Focosi 1, Massimo Franchini …

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - pubmed.ncbi.nlm.nih.gov
Background Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review.

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - europepmc.org
Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Efficacy of high-dose polyclonal intravenous immunoglobulin in COVID-19: a systematic review.

D Focosi, M Franchini, M Tuccori, M Cruciani - 2022 - cabidigitallibrary.org
Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - search.proquest.com
Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review.

D Focosi, M Franchini, M Tuccori, M Cruciani - Vaccines, 2022 - search.ebscohost.com
Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …